Compare Indo Boga Sukses Tbk. (IBOS) vs Merck Tbk. (MERK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indo Boga Sukses Tbk. vs Merck Tbk. — how do they compare? Indo Boga Sukses Tbk. trades at Rp68 (market cap 548.47B, 1.06M 24h volume), while Merck Tbk. trades at Rp3,850 (market cap 1.7T, 27.2K 24h volume). The key difference: Merck Tbk. is far larger — about 3.1× Indo Boga Sukses Tbk.'s market cap, and Indo Boga Sukses Tbk. is more actively traded (1.06M versus 27.2K). Which is the better fit depends on your goals.
| IBOS | MERK | |
|---|---|---|
Market Cap | 548.47B | 1.7T |
Volume | 1.06M | 27.2K |
Lot | 10.57K | 272 |
Turnover | 71.4M | 104.39M |
Average Price | 67.55 | 3,837.87 |
Value | 71.4M | 104.39M |
Indicative Equilibrium Price | — | 3,850 |
Indicative Equilibrium Volume | — | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indo Boga Sukses Tbk.
PT Indo Boga Sukses Tbk (”the Company”) was established based on notarial deed No. 6 dated January 16, 2019 of Tabitha Sri Jeany, S.H, MKn., notary in Yogyakarta.
Read more on IBOS →About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →
